This $250 Million Startup Tracks How Cancer Reacts To Treatment In Real Time

NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next up: using its quantum technology to design new drugs.
By Published On: Maggio 13, 2026Categories: DesignCommenti disabilitati su This $250 Million Startup Tracks How Cancer Reacts To Treatment In Real Time

Share This Story, Choose Your Platform!

About the author : admin